Danese S, Vermeire S, Zhou W, Pangan AL, Siffledeen J, Greenbloom S, et al
The Pharmacy Compounding Advisory Committee voted 8 to 6 in favor of recommending BPC-157 and KPV for the 503A bulks list, which governs what substances compounding pharmacies may legally produce
Tirzepatide (Mounjaro and Zepbound) and FDAs Drug Shortage List Tirzepatide, known by its brand names Mounjaro (for diabetes) and Zepbound (for weight loss), is a GLP-1 drug over which Eli Lilly & Co
drug prices with those in other developed nations, following an executive order issued in May 2025 for agencies to secure lower costs for consumers
Effectively disarms free radicals and prevents oxidative stress ( Glutathione antioxidant,CoQ10 and Alpha Lipoic Acid)
Chlorella vulgaris reduces the impact of stress on hypothalamic-pituitary-adrenal axis and brain c-fos expression